Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms27010048 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Patricia Bogdanov und 8 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain. Hauptthemen laut MEDLINE: Sitagliptin Phosphate, Glaucoma, Dexamethasone, Neuroprotective Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Industria, Economía y Competitividad, Instituto Carlos III-FEDER, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
Glaucoma is a neurodegenerative disease characterized by progressive degeneration of optic nerve axons and loss of retinal ganglion cells (RGCs). Although elevated intraocular pressure (IOP) is a major risk factor, many patients develop glaucoma with normal IOP, highlighting the need for neuroprotective therapies. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, has shown beneficial effects in diabetes-induced retinal neurodegeneration. This study aimed to evaluate whether sitagliptin eye drops, previously effective in diabetes-induced retinal neurodegeneration, could prevent corticosteroid-induced glaucoma. Glaucoma was induced in mice by periocular injection of dexamethasone (DEX) once weekly for five weeks. Sitagliptin or vehicle eye drops were administered from day 14 to 35. Untreated mice served as controls. DEX treatment caused significant loss of RGC bodies and optic nerve axons compared to controls, which was prevented by sitagliptin eye drops (p < 0.001), without affecting IOP. Sitagliptin also inhibited DEX-induced activation of macroglia and microglia and prevented oligodendrocyte loss. Furthermore, it suppressed overexpression of galectin-3 and gamma-synuclein in the optic nerve head (ONH) (p < 0.001), key mediators of inflammation and apoptosis. Sitagliptin eye drops exert a potent neuroprotective effect against corticosteroid-induced glaucoma, supporting their potential as a novel therapeutic strategy for glaucoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain.
- Ophthalmology Research Group, Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
ORCID-Profile: Patricia Bogdanov, Anna Duarri, David Sabater, Helena Isla-Magrané, Hugo Ramos, Anna Deàs-Just, Rafael Simó, Cristina Hernández
Förderung
- Ministerio de Industria, Economía y Competitividad
- Instituto Carlos III-FEDER
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Bogdanov, P., Duarri, A., Sabater, D., Canz, M. J., Isla-Magrané, H., Ramos, H., Deàs-Just, A., Simó, R., & Hernández, C. (2025). Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010048
Vancouver
Bogdanov P, Duarri A, Sabater D, Canz MJ, Isla-Magrané H, Ramos H, et al. Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010048
BibTeX
@article{Bogdanov2025,
author = {Bogdanov, Patricia and Duarri, Anna and Sabater, David and Canz, María José and Isla-Magrané, Helena and Ramos, Hugo and Deàs-Just, Anna and Simó, Rafael and Hernández, Cristina},
title = {Topical Administration of Sitagliptin Prevents Retinal Neurodegeneration in a Model of Glaucoma Induced by Dexamethasone},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms27010048}
}
EUVIMED